German Energy Services Stock News

Fresenius Medical Care (XTRA:FME) has been drifting quietly in recent weeks, but the stock’s mixed performance this year sets up an interesting question for investors: how do its improving profits square with the weaker share price? See our latest analysis for Fresenius Medical Care. Despite a softer 90 day share price return of 6.89 percent and a year to date share price return of 7.47 percent, Fresenius Medical Care’s improving fundamentals and solid three year total shareholder return of...

Wondering if adidas at €167.05 is a bargain in disguise or a value trap hiding behind a famous brand? This article is going to unpack what the current share price really implies. Despite being down 29.4% year to date and 28.6% over the last year, the stock has bounced 1.7% in the past week and 8.5% over the past month. This hints that sentiment around its 35.7% three year gain might be turning again. Recent headlines have focused on adidas refocusing its brand strategy, pushing performance...

BASF (XTRA:BAS) has been quietly grinding higher this month, and that steady climb is catching investor attention. The stock’s recent gains sit against a mixed multi year track record and improving earnings momentum. See our latest analysis for BASF. At around $44.02, BASF’s recent 1 month share price return of just over 5% hints that sentiment is stabilising. A 1 year total shareholder return of roughly 9% points to gradually rebuilding momentum rather than a sharp rerating. If BASF’s slow...

Siemens (XTRA:SIE) has quietly outperformed the wider European industrials group this year, and with the share price up roughly 4 % over the past month, investors are asking what is driving the momentum. See our latest analysis for Siemens. That momentum sits on top of a strong backdrop, with a roughly 23 % year to date share price return and multi year total shareholder returns comfortably ahead of many European peers. This suggests investors are leaning into Siemens digital and automation...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Siemens Energy AG ( ETR:ENR ) just reported healthy earnings but the stock price didn't move much. Our analysis...

The subdued stock price reaction suggests that TUI AG's ( ETR:TUI1 ) strong earnings didn't offer any surprises. We...

If you are wondering whether Henkel KGaA is quietly turning into a value opportunity while the market looks elsewhere, this article will walk you through whether the current price actually makes sense. The stock is up 2.1% over the last week but is roughly flat over the past month and still down 15.3% year to date and 13.0% over the last year. This pattern suggests sentiment has been cautious despite a 14.8% gain over three years. Recent headlines have focused on Henkel's ongoing portfolio...

thyssenkrupp nucera KGaA (XTRA:NCH2) just landed a high double digit million euro contract to supply electrolysers for a new large scale Chlor Alkali plant in the Middle East, sharpening attention on its stock. See our latest analysis for thyssenkrupp nucera KGaA. The latest contract win comes after a choppy spell for the stock, with a 90 day share price return of minus 19.54 percent and a 1 year total shareholder return of minus 23.44 percent. This suggests sentiment may be stabilising...

Earlier this month, Kepler Cheuvreux upgraded Deutsche Lufthansa’s rating from Hold to Buy, highlighting progress in its turnaround program and potential benefits from sector-wide factors like capacity constraints and lower fuel costs. The broker also pointed to Lufthansa’s growing focus on premium long-haul travel and its Eurowings expansion as areas where shifting global demand patterns could enhance the group’s competitive position. Next, we’ll examine how this upgrade and confidence in...

Earlier this month, Fresenius SE & Co. KGaA held its Analyst/Investor Day, outlining a plan to double its biopharma revenue and portfolio by 2030 while targeting a 20% EBIT margin through innovation, cost leadership, and global commercial expansion. Management emphasized that a robust biopharma pipeline, strong underlying financial performance, and significant R&D and manufacturing investments are intended to support this long-term value creation roadmap. We’ll now explore how Fresenius’s...

Stabilus SE's ( ETR:STM ) earnings announcement last week didn't impress shareholders. Despite the soft profit numbers...

We feel now is a pretty good time to analyse SBF AG's ( FRA:CY1K ) business as it appears the company may be on the...

Unless you borrow money to invest, the potential losses are limited. But when you pick a company that is really...

Let's talk about the popular Heidelberg Materials AG ( ETR:HEI ). The company's shares saw a decent share price growth...

In recent days, Lemongrass and RESAAS each announced new partnerships with SAP under the PartnerEdge program, aiming to embed their AI and real-time data solutions more tightly into SAP’s Business Technology Platform and enterprise analytics stack. These collaborations, together with SAP’s emphasis on an application–data–AI flywheel and employee-led innovation, underline how the company is working to keep its software central to mission-critical workflows as customers modernize in an AI...

In December 2025, AlzChem Group AG approved a roughly €120 million investment program to build a more automated creatine production plant and related infrastructure, with phased commissioning scheduled from the second half of 2027 to capture additional demand in sports, food, and health. The company links this capacity expansion to early triple-digit million euro annual sales potential from its Creapure® and Creavitalis® lines, underscoring how nutrition and wellness trends are reshaping its...

Siemens Healthineers AG previously announced an annual dividend of €1.00 per share, payable on February 10, 2026, with an ex-dividend date of February 6, 2026 and a record date of February 9, 2026. ALZpath, Inc. has licensed its proprietary pTau217 antibody to Siemens Healthineers, enabling development of an Alzheimer's diagnostic assay for Atellica systems that could expand the company’s higher-value in vitro testing portfolio. We’ll now examine how adding an ALZpath-powered Alzheimer’s...

TUI (XTRA:TUI1) just wrapped up its fiscal year with higher sales and net income than last year, and paired those results with a fresh annual dividend announcement that underlines management’s confidence. See our latest analysis for TUI. The upbeat full year numbers and fresh dividend seem to have lit a fire under sentiment, with a 30 day share price return of 14.61 percent helping push the stock to 8.878 dollars, even though the five year total shareholder return remains negative. This...

TeamViewer recently appointed Finn Faldi as Executive Vice President Global Inside Sales, adding him to the Senior Leadership Team to unify inside sales across the Americas, EMEA and APAC, while President TeamViewer Americas Georg Beyschlag is set to depart after more than seven years in leadership roles. Faldi’s return, following his prior tenure scaling TeamViewer’s Americas operations and later advising the company, underscores management’s focus on sharpening its commercial engine to...

Deutsche Lufthansa (XTRA:LHA) jumped after Kepler Cheuvreux raised its rating to Buy, highlighting a turnaround plan that is mostly scheduled for execution next year along with improving conditions in long-haul travel. See our latest analysis for Deutsche Lufthansa. The rating upgrade lands on top of already strong momentum, with a 37.48% year to date share price return and a 33.38% one year total shareholder return suggesting confidence in Lufthansa’s multi year recovery story. If this...

As the European markets navigate mixed performances, with notable fluctuations in major indices like Germany’s DAX and France’s CAC 40, investors continue to assess opportunities amidst economic uncertainties. Penny stocks, though a term from past market eras, still hold potential for those seeking value in smaller or newer companies. These stocks can offer affordability and growth potential when supported by strong financials, making them intriguing options for investors looking beyond...

With a price-to-earnings (or "P/E") ratio of 24.5x Fresenius SE & Co. KGaA ( ETR:FRE ) may be sending bearish signals...

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") above 18x, you may consider...